Terms: = Kidney tumors AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Prognosis
17 results:
1. The Value of Dual-Energy Computed Tomography-Based Radiomics in the Evaluation of Interstitial Fibers of Clear Cell Renal Carcinoma.
Bing X; Wang N; Li Y; Sun H; Yao J; Li R; Li Z; Ouyang A
Technol Cancer Res Treat; 2024; 23():15330338241235554. PubMed ID: 38404055
[TBL] [Abstract] [Full Text] [Related]
2. Single-cell disulfidptosis regulator patterns guide intercellular communication of tumor microenvironment that contribute to kidney renal clear cell carcinoma progression and immunotherapy.
Xu K; Li D; Qian J; Zhang Y; Zhang M; Zhou H; Hou X; Jiang J; Zhang Z; Sun H; Shi G; Dai H; Liu H
Front Immunol; 2024; 15():1288240. PubMed ID: 38292868
[TBL] [Abstract] [Full Text] [Related]
3. Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and birc3 in clear cell renal cell carcinoma.
Wei K; Zhang X; Yang D
PeerJ; 2023; 11():e16643. PubMed ID: 38130918
[TBL] [Abstract] [Full Text] [Related]
4. Protein Arginine Methyltransferases Refine the Classification of Clear Cell Renal Cell Carcinoma with Distinct prognosis and Tumor Microenvironment Characteristics.
Ye S; Tian X; Anwaier A; Wei S; Liu W; Su J; Zhu S; Dai B; Gu J; Qu Y; Xu W; Zhang H; Ye D
Int J Biol Sci; 2023; 19(14):4552-4570. PubMed ID: 37781030
[No Abstract] [Full Text] [Related]
5. [Development and validation of a prognostic model for patients with sepsis in intensive care unit].
Jiang Z; Wang H; Wang S; Guan C; Qu Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):800-806. PubMed ID: 37593856
[TBL] [Abstract] [Full Text] [Related]
6. Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15).
Boulenger de Hauteclocque A; Ferrer L; Ambrosetti D; Ricard S; Bigot P; Bensalah K; Henon F; Doumerc N; Méjean A; Verkarre V; Dariane C; Larré S; Champy C; de La Taille A; Bruyère F; Rouprêt M; Paparel P; Droupy S; Fontenil A; Patard JJ; Durand X; Waeckel T; Lang H; Lebâcle C; Guy L; Pignot G; Durand M; Long JA; Charles T; Xylinas E; Boissier R; Yacoub M; Colin T; Bernhard JC
BJU Int; 2023 Aug; 132(2):160-169. PubMed ID: 36648124
[TBL] [Abstract] [Full Text] [Related]
7. Identification and validation of ubiquitin-proteasome system related genes as a prognostic signature for papillary renal cell carcinoma.
Zhang X; Liu X; Xiong R; An HX
Aging (Albany NY); 2022 Nov; 14(23):9599-9616. PubMed ID: 36385010
[TBL] [Abstract] [Full Text] [Related]
8. The Identification of Zinc-Finger Protein 433 as a Possible Prognostic Biomarker for Clear-Cell Renal Cell Carcinoma.
Heyliger SO; Soliman KFA; Saulsbury MD; Reams RR
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439859
[TBL] [Abstract] [Full Text] [Related]
9. A novel imaging based Nomogram for predicting post-surgical biochemical recurrence and adverse pathology of prostate cancer from pre-operative bi-parametric MRI.
Li L; Shiradkar R; Leo P; Algohary A; Fu P; Tirumani SH; Mahran A; Buzzy C; Obmann VC; Mansoori B; El-Fahmawi A; Shahait M; Tewari A; Magi-Galluzzi C; Lee D; Lal P; Ponsky L; Klein E; Purysko AS; Madabhushi A
EBioMedicine; 2021 Jan; 63():103163. PubMed ID: 33321450
[TBL] [Abstract] [Full Text] [Related]
10. The Association Between Small Primary Tumor Size and prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.
DiNatale RG; Xie W; Becerra MF; Silagy AW; Attalla K; Sanchez A; Mano R; Marcon J; Blum KA; Benfante NE; Voss MH; Motzer RJ; Coleman J; Choueiri TK; Reznik E; Russo P; Heng DYC; Hakimi AA
Eur Urol Oncol; 2020 Feb; 3(1):47-56. PubMed ID: 31735646
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathologic features associated with survival after cytoreductive nephrectomy for nonclear cell renal cell carcinoma.
Silagy AW; Flynn J; Mano R; Blum KA; Marcon J; DiNatale RG; Sanchez A; Carlo MI; Motzer RJ; Coleman JA; Russo P; Ostrovnaya I; Chen YB; Hakimi AA
Urol Oncol; 2019 Nov; 37(11):811.e9-811.e16. PubMed ID: 31521530
[TBL] [Abstract] [Full Text] [Related]
12. Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma.
Zhang X; Yin X; Zhang H; Sun G; Yang Y; Chen J; Shu K; Zhao J; Zhao P; Chen N; Wang J; Shen P; Zeng H
BMC Cancer; 2019 Jan; 19(1):49. PubMed ID: 30630458
[TBL] [Abstract] [Full Text] [Related]
13. Nivolumab versus Cabozantinib: Comparing Overall Survival in Metastatic Renal Cell Carcinoma.
Wiecek W; Karcher H
PLoS One; 2016; 11(6):e0155389. PubMed ID: 27271250
[TBL] [Abstract] [Full Text] [Related]
14. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM
Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892
[TBL] [Abstract] [Full Text] [Related]
15. [Nephroblastoma - 30-years period of its treatment in the University Hospital Motol, Prague].
Mališ J; Švojgr K; Pýcha K; Jeřábková V; Cyprová S; Churáčková M; Šmelhaus V; Radvanský J; Zítková M; Kodet R; Kodetová D; Malinová B; Koutecký J; Šnajdauf J; Starý J
Klin Onkol; 2013; 26(5):336-42. PubMed ID: 24107156
[TBL] [Abstract] [Full Text] [Related]
16. c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma.
Gibney GT; Aziz SA; Camp RL; Conrad P; Schwartz BE; Chen CR; Kelly WK; Kluger HM
Ann Oncol; 2013 Feb; 24(2):343-349. PubMed ID: 23022995
[TBL] [Abstract] [Full Text] [Related]
17. [Diagnosis and surgical management of renal cell carcinoma with inferior vena cava tumor thrombus--a report of 6 cases with literature review].
Li XD; Cheng S; Rui XF; Li GH; Chen YB; Yu DM
Ai Zheng; 2005 Nov; 24(11):1394-7. PubMed ID: 16552970
[TBL] [Abstract] [Full Text] [Related]